DI BRIZZI, FRANCESCO
 Distribuzione geografica
Continente #
AS - Asia 188
NA - Nord America 73
EU - Europa 45
SA - Sud America 19
OC - Oceania 3
AF - Africa 1
Totale 329
Nazione #
US - Stati Uniti d'America 65
SG - Singapore 49
CN - Cina 43
VN - Vietnam 38
HK - Hong Kong 36
IT - Italia 20
BR - Brasile 15
RU - Federazione Russa 9
IN - India 5
JP - Giappone 5
DE - Germania 4
FR - Francia 4
MX - Messico 4
CA - Canada 3
FI - Finlandia 3
GB - Regno Unito 3
KR - Corea 3
AR - Argentina 2
ID - Indonesia 2
PH - Filippine 2
AE - Emirati Arabi Uniti 1
AU - Australia 1
CL - Cile 1
CZ - Repubblica Ceca 1
EC - Ecuador 1
LB - Libano 1
NZ - Nuova Zelanda 1
PL - Polonia 1
PW - Palau 1
SV - El Salvador 1
TH - Thailandia 1
TW - Taiwan 1
UZ - Uzbekistan 1
ZA - Sudafrica 1
Totale 329
Città #
Hong Kong 35
Singapore 27
Hefei 18
Naples 16
San Jose 12
Hanoi 11
Los Angeles 11
Ho Chi Minh City 10
New York 9
Ashburn 6
Beijing 6
Council Bluffs 3
Moscow 3
Munich 3
Seoul 3
São Paulo 3
Tokyo 3
Atlanta 2
Boardman 2
Chaozhou 2
Dallas 2
Guangzhou 2
Lauterbourg 2
Orem 2
Querétaro 2
Thái Nguyên 2
Turku 2
Altoona 1
Araxá 1
Beaverton 1
Belo Horizonte 1
Belém 1
Bengaluru 1
Bhiwāni 1
Biên Hòa 1
Brasília 1
Buffalo 1
Cape Town 1
City of London 1
Da Nang 1
Delhi 1
Denver 1
Dongguan 1
Frankfurt am Main 1
Gramado 1
Guarulhos 1
Guayaquil 1
Haiphong 1
Honolulu 1
Hải Dương 1
Itajubá 1
Kochi 1
Lappeenranta 1
London 1
Long Xuyen 1
Lấp Vò 1
Makassar 1
Marseille 1
Mexico City 1
Miramar 1
Misterbianco 1
Montreal 1
Nagpur 1
New Taipei City 1
Ngerulmud 1
Nova Friburgo 1
Osaka 1
Padre Hurtado 1
Paranaíba 1
Passo Fundo 1
Pattaya 1
Prague 1
Queimados 1
Rome 1
San Carlos de Bolívar 1
San Salvador 1
Santa Clara 1
Sydney 1
São Carlos 1
Tarlac City 1
Tashkent 1
Tokushima 1
Toronto 1
Torreón 1
Warsaw 1
Wellington 1
Whitby 1
Totale 259
Nome #
Efficacy of Molnupiravir in Reducing the Risk of Severe Outcomes in Patients with SARS-CoV-2 Infection: A Real-Life Full-Matched Case–Control Study (SAVALO Study) 166
Correction: Efficacy of Nirmatrelvir/ritonavir in reducing the risk of severe outcome in patients with SARS-CoV-2 infection: a real-life full-matched case–control study (SAVALO Study)(BMC Infect Dis., (2024), 24, 1434, 10.1186/s12879-024-10303-5) 138
Efficacy of Nirmatrelvir/ritonavir in reducing the risk of severe outcome in patients with SARS-CoV-2 infection: a real-life full-matched case-control study (SAVALO Study) 30
Totale 334
Categoria #
all - tutte 598
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 598


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2024/202562 0 0 0 0 0 0 0 0 0 0 0 62
2025/2026272 28 37 26 37 32 12 24 26 32 18 0 0
Totale 334